Key role for respiratory CD103(+) dendritic cells, IFN-γ, and IL-17 in protection against Streptococcus pneumoniae infection in response to α-galactosylceramide.
暂无分享,去创建一个
J. Sirard | A. Benecke | B. Frisch | C. Paget | F. Trottein | S. Ivanov | B. Ryffel | J. Chabalgoity | L. Van Maele | I. Maillet | C. Faveeuw | J. Fontaine | J. Renneson | H. Léger | A. Rial | Elodie Macho Fernandez | Natalia Muñoz Wolf | Stoyan Ivanov
[1] J. Sirard,et al. Protection against Streptococcus pneumoniae serotype 1 acute infection shows a signature of Th17- and IFN-γ-mediated immunity. , 2012, Immunobiology.
[2] J. Linden,et al. Leukocyte compartments in the mouse lung: distinguishing between marginated, interstitial, and alveolar cells in response to injury. , 2012, Journal of immunological methods.
[3] Dapeng Zhou,et al. Intranasal but not intravenous delivery of the adjuvant α‐galactosylceramide permits repeated stimulation of natural killer T cells in the lung , 2011, European journal of immunology.
[4] D. Riches,et al. Lung dendritic cells at the innate‐adaptive immune interface , 2011, Journal of leukocyte biology.
[5] P. Savage,et al. Airborne lipid antigens mobilize resident intravascular NKT cells to induce allergic airway inflammation , 2011, The Journal of experimental medicine.
[6] M. Si-Tahar,et al. Potential Role of Invariant NKT Cells in the Control of Pulmonary Inflammation and CD8+ T Cell Response during Acute Influenza A Virus H3N2 Pneumonia , 2011, The Journal of Immunology.
[7] R. Das,et al. A Family of IFN-γ–Inducible 65-kD GTPases Protects Against Bacterial Infection , 2011, Science.
[8] J. Sirard,et al. Mucosal Administration of Flagellin Protects Mice from Streptococcus pneumoniae Lung Infection , 2010, Infection and Immunity.
[9] J. Sirard,et al. TLR5 Signaling Stimulates the Innate Production of IL-17 and IL-22 by CD3negCD127+ Immune Cells in Spleen and Mucosa , 2010, The Journal of Immunology.
[10] L. Tora,et al. TAF6δ orchestrates an apoptotic transcriptome profile and interacts functionally with p53 , 2010, BMC Molecular Biology.
[11] F. Barré-Sinoussi,et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. , 2009, The Journal of clinical investigation.
[12] S. Opal,et al. Pathogenesis, treatment, and prevention of pneumococcal pneumonia , 2009, The Lancet.
[13] H. Hammad,et al. Biology of lung dendritic cells at the origin of asthma. , 2009, Immunity.
[14] M. Capron,et al. Role of Marginal Zone B Lymphocytes in Invariant NKT Cell Activation1 , 2009, The Journal of Immunology.
[15] M. Brenner,et al. Chapter 1 Antigen Presentation by CD1 , 2009 .
[16] M. Brenner,et al. Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity. , 2009, Advances in immunology.
[17] V. Cerundolo,et al. Harnessing invariant NKT cells in vaccination strategies , 2009, Nature Reviews Immunology.
[18] M. Lipsitch,et al. Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization , 2008, PLoS pathogens.
[19] A. Chiba,et al. Rapid NKT Cell Responses Are Self-Terminating during the Course of Microbial Infection1 , 2008, The Journal of Immunology.
[20] M. Smyth,et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17–producing CD4−NK1.1− NKT cell population , 2008, Proceedings of the National Academy of Sciences.
[21] Brenton L. Scott,et al. Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice. , 2008, American journal of respiratory and critical care medicine.
[22] Jeffrey D. Morton,et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease , 2008, Nature Medicine.
[23] Hyun-Jeong Ko,et al. A distinct subset of natural killer T cells produces IL-17, contributing to airway infiltration of neutrophils but not to airway hyperreactivity. , 2008, Cellular immunology.
[24] Michael B. Brenner,et al. CD1 antigen presentation: how it works , 2007, Nature Reviews Immunology.
[25] Anneliese O. Speak,et al. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. , 2007, Immunity.
[26] E. Kremmer,et al. CD103− and CD103+ Bronchial Lymph Node Dendritic Cells Are Specialized in Presenting and Cross-Presenting Innocuous Antigen to CD4+ and CD8+ T Cells1 , 2007, The Journal of Immunology.
[27] Chi‐Huey Wong,et al. Identification of an IL-17–producing NK1.1neg iNKT cell population involved in airway neutrophilia , 2007, The Journal of experimental medicine.
[28] Albert Bendelac,et al. The biology of NKT cells. , 2007, Annual review of immunology.
[29] Y. Iwakura,et al. Role of interferon-γ in Vα14+ natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs , 2007 .
[30] Y. Iwakura,et al. Role of interferon-gamma in Valpha14+ natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs. , 2007, Microbes and infection.
[31] S. Martens,et al. The interferon-inducible GTPases. , 2006, Annual review of cell and developmental biology.
[32] D. Chung,et al. FcgammaRIII engagement provides activating signals to NKT cells in antibody-induced joint inflammation. , 2006, The Journal of clinical investigation.
[33] S. Ju,et al. A Major Lung CD103 (αE)-β7 Integrin-Positive Epithelial Dendritic Cell Population Expressing Langerin and Tight Junction Proteins1 , 2006, The Journal of Immunology.
[34] S. Ju,et al. A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. , 2006, Journal of immunology.
[35] A. Tomasz,et al. Serotypes and clonal types of penicillin-susceptible streptococcus pneumoniae causing invasive disease in children in five Latin American countries. , 2005, Microbial drug resistance.
[36] L. Kaer,et al. Innate Immunity: NKT Cells in the Spotlight , 2005, Current Biology.
[37] Chyung-Ru Wang,et al. Long‐term loss of canonical NKT cells following an acute virus infection , 2005, European journal of immunology.
[38] B. Garvy,et al. The importance of neutrophils in resistance to pneumococcal pneumonia in adult and neonatal mice , 1996, Inflammation.
[39] M. Kronenberg,et al. Going both ways: immune regulation via CD1d-dependent NKT cells. , 2004, The Journal of clinical investigation.
[40] J. Chabalgoity,et al. Intranasal Immunization with a Colloid-Formulated Bacterial Extract Induces an Acute Inflammatory Response in the Lungs and Elicits Specific Immune Responses , 2004, Infection and Immunity.
[41] N. Rooijen,et al. Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate , 1984, Cell and Tissue Research.
[42] M. Taniguchi,et al. Critical role of Vα14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection , 2003, European journal of immunology.
[43] Steffen Jung,et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. , 2002, Immunity.
[44] J. Glickman,et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung , 2002, Nature Medicine.
[45] J. A. Hobbs,et al. Selective Loss of Natural Killer T Cells by Apoptosis following Infection with Lymphocytic Choriomeningitis Virus , 2001, Journal of Virology.
[46] J. Shellito,et al. Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense , 2001, The Journal of experimental medicine.
[47] C. Feldman,et al. Streptococcus pneumoniae respiratory tract infections. , 2001, Current opinion in infectious diseases.
[48] G. Siber,et al. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[49] Hiroshi Sato,et al. Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors , 1997 .
[50] M. Taniguchi,et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. , 1997, Science.
[51] T. Standiford,et al. Expression and regulation of chemokines in bacterial pneumonia , 1996, Journal of leukocyte biology.
[52] J. Yewdell,et al. CD1 recognition by mouse NK1+ T lymphocytes. , 1995, Science.
[53] H. Reynolds,et al. Macrophages and polymorphonuclear neutrophils in lung defense and injury. , 1990, The American review of respiratory disease.
[54] N. Van Rooijen,et al. Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate. An enzyme-histochemical study. , 1984, Cell and tissue research.